Skip to content

Opening book details…

Can I read 194P Modelling strategies to combine multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer on EtoBox?

194P Modelling strategies to combine multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer by F. van Delft; M. Schuurbiers; M. Muller; S. Burgers; H. van Rossum; M. Ijzerman; M. van den Heuvel; H. Koffijberg is a Medicine article available to read on EtoBox.

What is 194P Modelling strategies to combine multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer about?

progressive disease: 55.6% in the recurrence group and 43.6% in the no recurrence group.Conclusions: 40.6% of patients had a recurrence of ICI-ILD after rechallenge with ICI. The second episode of ICI-ILD appears to have similar radiological patterns but to be more severe and to occur earlier than the first one.

Who reads 194P Modelling strategies to combine multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer?

It is typically read by researchers, students, and practitioners in Medicine.

Author
F. van Delft; M. Schuurbiers; M. Muller; S. Burgers; H. van Rossum; M. Ijzerman; M. van den Heuvel; H. Koffijberg
Publisher
Elsevier BV
Published
2022
Language
EN
Field
Medicine (Health Sciences)

More by F. van Delft; M. Schuurbiers; M. Muller; S. Burgers; H. van Rossum; M. Ijzerman; M. van den Heuvel; H. Koffijberg

Browse all works by F. van Delft; M. Schuurbiers; M. Muller; S. Burgers; H. van Rossum; M. Ijzerman; M. van den Heuvel; H. Koffijberg